Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Other Current Payables: €97.2 Mil (As of Dec. 2025)


STU:JIL Jilin Province Huinan Changlong Bio-pharmacy Co Ltd STU:JIL
81 GF Score
Price €0.25
GF Value €0.18
! 1 Warning Sign
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Other Current Payables?

Jilin Province Huinan Changlong Bio-pharmacy Co STU:JIL 81 Other Current Payables is €97.2 Mil as of Dec. 2025. GuruFocus rates STU:JIL with a GF Score™ of 81/100 and a GF Value™ of €0.18. The stock has 1 warning sign investors should review.

Jilin Province Huinan Changlong Bio-pharmacy Co's Other Current Payables for the quarter that ended in Dec. 2025 was €97.2 Mil.

Jilin Province Huinan Changlong Bio-pharmacy Co's quarterly Other Current Payables declined from Dec. 2024 (€88.5 Mil) to Jun. 2025 (€82.9 Mil) but then increased from Jun. 2025 (€82.9 Mil) to Dec. 2025 (€97.2 Mil).

Jilin Province Huinan Changlong Bio-pharmacy Co's annual Other Current Payables increased from Dec. 2023 (€40.3 Mil) to Dec. 2024 (€88.5 Mil) and increased from Dec. 2024 (€88.5 Mil) to Dec. 2025 (€97.2 Mil).

Jilin Province Huinan Changlong Bio-pharmacy Co Other Current Payables Related Terms

Jilin Province Huinan Changlong Bio-pharmacy Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jilin Province Huinan Changlong Bio-pharmacy Co Other Current Payables Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.72 40.98 40.26 88.45 97.19

Jilin Province Huinan Changlong Bio-pharmacy Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.26 72.89 88.45 82.88 97.19
STU:JIL
81GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd STU:JIL
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €97.2 Mil mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a Other Current Payables of €97.2 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Other Current Payables too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Other Current Payables is €97.2 Mil. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Other Current Payables compare to ZTS and UTHR?
Jilin Province Huinan Changlong Bio-pharmacy Co's Other Current Payables of €97.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. Jilin Province Huinan Changlong Bio-pharmacy Co's current Other Current Payables is €97.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a current Other Current Payables of €97.2 Mil. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current Other Current Payables is €97.2 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL), the current Other Current Payables is €97.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.

Key valuation signals for STU:JIL:

  • Other Current Payables: €97.2 Mil
  • GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the STU:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges 08049:Hong KongJIL:Germany
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score

Get the complete analysis for STU:JIL

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.18
GF Value